Systemic inflammation increases intestinal permeability during experimental human endotoxemia

Shock

Volumn 32, Issue 4, 2009, Pages 374-378

  Hietbrink, Falco ^a   Besselink, Marc G H ^a   Renooij, Willem ^a   De Smet, Martin B M ^a   Draisma, Annelies ^b   Van Der Hoeven, Hans ^b   Pickkers, Peter ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Endotoxemia; I FABP; Intestinal permeability; Polyethylene glycol; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

FATTY ACID BINDING PROTEIN; INTERLEUKIN 10; MACROGOL;

ADULT; ARTICLE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI INFECTION; EXPERIMENTAL INFECTION; HUMAN; HUMAN EXPERIMENT; INTESTINE CELL; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; NORMAL HUMAN; PROTEIN BLOOD LEVEL; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; URINARY EXCRETION;

ADULT; ENDOTOXEMIA; FATTY ACID-BINDING PROTEINS; HUMANS; INTERLEUKIN-10; INTESTINES; LIPOPOLYSACCHARIDES; POLYETHYLENE GLYCOLS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 70349664579     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181a2bcd6     Document Type: Article

References (31)

1. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ-failure syndrome. Arch Surg 121:196-208, 1986.
2. Deitch EA, Berg R: Bacterial translocation from the gut: A mechanism of infection. J Burn Care Rehabil 8:475-482, 1987.
3. Oudemans-van Straaten HM, van der Voort PJ, Hoek FJ, Bosman RJ, van der Spoel JI, Zandstra DF: Pitfalls in gastrointestinal permeability measurement in ICU patients with multiple organ failure using differential sugar absorption. Intensive Care Med 28:130-138, 2002.
4. Hietbrink F, Besselink MG, Renooij W, Leenen LP: Pitfalls in gastrointestinal permeability measurement in ICU patients. Intensive Care Med 33:2216, 2007.
5. Soeters PB, Luyer MD, Greve JW, Buurman WA: The significance of bowel permeability. Curr Opin Clin Nutr Metab Care 10:632-638, 2007.
6. Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, Delude RL, Fink MP: IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 285: G621-G629, 2003.
7. Han X, Fink MP, Delude RL: Proinflammatory cytokines cause NO*- dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19:229-237, 2003.
8. Parlesak A, Bode JC, Bode C: Parallel determination of gut permeability in man with M(r) 400, M(r) 1500, M(r) 4000 and M(r) 10,000 polyethylene glycol. Eur J Clin Chem Clin Biochem 32:813-820, 1994.
9. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C: Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32:742-747, 2000.
10. Goldman RC, Leive L: Heterogeneity of antigenic-side-chain length in lipopolysaccharide from Escherichia coli 0111 and Salmonella typhimurium LT2. Eur J Biochem 107:145-153, 1980.
11. Bahador M, Cross AS: Review: From therapy to experimental model: A hundred years of endotoxin administration to human subjects. J Endotoxin Res 13:251-279, 2007.
12. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280-287, 1989.
13. Mittermayer F, Pleiner J, Schaller G, Weltermann A, Kapiotis S, Jilma B, Wolzt M: Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin-induced acute inflammation in humans. Eur J Clin Invest 33:758-761, 2003.
14. van Eijk LT, Pickkers P, Smits P, van den BW, Bouw MP, van der Hoeven JG: Microvascular permeability during experimental human endotoxemia: An open intervention study. Crit Care 9:R157-R164, 2005.
15. Branger J, van den BB, Weijer S, Gupta A, van Deventer SJ, Hack CE, Peppelenbosch MP, van der PT: Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia. Blood 101:4446-4448, 2003.
16. Heemskerk S, Pickkers P, Bouw MP, Draisma A, van der Hoeven JG, Peters WH, Smits P, Russel FG, Masereeuw R: Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol 1:853-862, 2006.
17. Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, Ono T, Hatakeyama K: Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 110:339-343, 1996.
18. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW: A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 123:1459-1464, 1988.
19. Jorgensen VL, Ibsen M, Andresen L, Schulzke JD, Perner A: Effects of endotoxaemia on markers of permeability, metabolism and inflammation in the large bowel of healthy subjects. Acta Anaesthesiol Scand 51: 1085-1092, 2007.
20. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, Meddings JB: Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 158:444-451, 1998.
21. Johnston JD, Harvey CJ, Menzies IS, Treacher DF: Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 24:1144-1149, 1996.
22. Harris CE, Griffiths RD, Freestone N, Billington D, Atherton ST, Macmillan RR: Intestinal permeability in the critically ill. Intensive Care Med 18: 38-41, 1992.
23. Ammori BJ, Leeder PC, King RF, Barclay GR, Martin IG, Larvin M, McMahon MJ: Early increase in intestinal permeability in patients with severe acute pancreatitis: Correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 3:252-262, 1999.
24. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U: Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286:944-953, 2001.
25. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH: Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584-1589, 1999.
26. Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, Romaschin AD, Derzko AN: Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit Care 6: 342-348, 2002.
27. Menezes MJ, Costa DJ, Clarencio J, Miranda JC, Barral A, Barral-Netto M, Brodskyn C, de Oliveira CI: Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva. BMC Immunol 9:12, 2008.
28. van Eijk LT, Nooteboom A, Hendriks T, Sprong T, Netea MG, Smits P, van der Hoeven JG, Pickkers P: Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro. Shock 25:358-362, 2006.
29. van Dissel JT, van LP, Westendorp RG, Kwappenberg K, Frolich M: Antiinflammatory cytokine profile and mortality in febrile patients. Lancet 351:950-953, 1998.
30. Rajan S, Vyas D, Clark AT, Woolsey CA, Clark JA, Hotchkiss RS, Buchman TG, Coopersmith CM: Intestine-specific overexpression of IL-10 improves survival in polymicrobial sepsis. Shock 29:483-489, 2007.
31. Lu J, Philpott DJ, Saunders PR, Perdue MH, Yang PC, McKay DM: Epithelial ion transport and barrier abnormalities evoked by superantigen-activated immune cells are inhibited by interleukin-10 but not interleukin-4. J Pharmacol Exp Ther 287:128-136, 1998.